Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 4Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 470Neoplasms 328Colorectal Neoplasms 237Carcinoma, Non-Small-Cell Lung 232Lung Neoplasms 202Prostatic Neoplasms 181Carcinoma, Hepatocellular 173Stomach Neoplasms 138Pancreatic Neoplasms 124Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 104Multiple Myeloma 92Recurrence 87Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 78Neoplasm Metastasis 76Ovarian Neoplasms 74Colonic Neoplasms 69Brain Neoplasms 68Triple Negative Breast Neoplasms 66Esophageal Neoplasms 66Glioblastoma 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Motor Activity 55Small Cell Lung Carcinoma 54Disease 54Hematologic Neoplasms 53Glioma 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Myeloid Malignancies × Clear all
NCT06917105 2025-04-08

Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies

Tongji Hospital

Phase 1/2 Not yet recruiting
45 enrolled

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡